Xinya Xu | Dermatology | Best Researcher Award

Dr. Xinya Xu | Dermatology | Best Researcher Award

Resident Physician from Shenzhen People’s Hospital, China

Dr. Xinya Xu is an accomplished physician-scientist specializing in dermatology, with a research focus on pigmentary disorders and photoaging. Her academic journey began with a Bachelor of Medicine in Integrated Chinese and Western Clinical Medicine, followed by advanced studies culminating in a Ph.D. in Dermatology and Venereology from Fudan University, one of China’s leading institutions. Over the years, Dr. Xu has developed a notable academic and clinical profile through her work in prestigious hospitals such as the Third Affiliated Hospital of Sun Yat-Sen University and currently Shenzhen People’s Hospital. She has authored numerous peer-reviewed publications in high-impact journals, often as the first author, demonstrating a consistent and focused commitment to scientific inquiry. Her research addresses the immunological and molecular mechanisms of skin conditions, such as vitiligo and photoaging, offering innovative insights into the pathophysiology and potential therapeutic targets. Dr. Xu has also secured provincial-level research grants and earned multiple academic awards and scholarships, showcasing her dedication to excellence. She remains an active member of the Asian Society for Pigment Cell Research. With her blend of clinical experience, research acumen, and academic recognition, Dr. Xu is an exemplary candidate for accolades such as the Best Researcher Award.

Professional Profile

Education

Dr. Xinya Xu’s academic background reflects a progressive and well-rounded education in dermatology and integrated medical science. She began her higher education at Nanjing University of Chinese Medicine, where she earned a Bachelor of Medicine in Integrated Chinese and Western Clinical Medicine between 2009 and 2014. This foundational training offered her a unique dual perspective on healthcare, enabling her to appreciate traditional and modern approaches to patient care and disease management. She then pursued her Master’s degree in Dermatology and Venereology at Sun Yat-Sen University from 2014 to 2017. This experience allowed her to delve deeper into specialized areas of dermatological research and practice, laying the groundwork for future scientific contributions. Determined to further expand her expertise, Dr. Xu enrolled in the Doctor of Philosophy program in Dermatology and Venereology at Fudan University, Shanghai, completing it in 2021. Fudan University, a top-tier research institution in China, provided her with access to advanced training, leading mentors, and cutting-edge laboratories. Each stage of her academic journey contributed significantly to shaping her current capabilities as a physician and researcher. Her educational trajectory underscores her strong foundation, intellectual rigor, and commitment to continuous professional development in clinical dermatology and biomedical research.

Professional Experience

Dr. Xinya Xu has cultivated significant professional experience in dermatology through her clinical roles and academic positions in prominent Chinese medical institutions. She is currently serving as a resident physician in the Department of Dermatology at Shenzhen People’s Hospital (since February 2025), where she applies her clinical and research expertise in patient care and diagnostic evaluation. Before this, she worked as both a resident physician and post-doctoral fellow at the Third Affiliated Hospital of Sun Yat-Sen University in Guangzhou from August 2021 to August 2024. This role allowed her to bridge clinical practice and translational research, contributing to her development as a clinician-scientist. During her post-doctoral tenure, Dr. Xu engaged in complex dermatological cases, supervised clinical trials, and collaborated with research teams on investigative studies related to vitiligo and photoaging. Her responsibilities included patient management, data collection, manuscript writing, and collaboration with interdisciplinary teams. Her professional background is characterized by a dual emphasis on high-quality patient care and rigorous scientific exploration. Through hands-on experience in both general dermatology and subspecialties, she has acquired the skills necessary to navigate clinical challenges while advancing the scientific understanding of skin diseases. Her work exemplifies integration between clinical duties and biomedical research.

Research Interests

Dr. Xinya Xu’s research interests are focused primarily on the immunological and molecular mechanisms underlying pigmentary skin disorders and photoaging. She has conducted in-depth investigations into the pathogenesis of vitiligo, particularly exploring the immune response and pyroptosis of melanocytes via the cGAS-STING pathway. This work contributes to understanding the autoimmune processes involved in depigmentation and provides potential avenues for therapeutic intervention. Additionally, Dr. Xu is interested in skin photoaging and the role of aging-related biomarkers such as CD47 and Cathepsin D. Her research has revealed how these factors impair macrophage function and accelerate skin aging, thus offering new biomarkers and treatment strategies. Another important dimension of her research is the interaction between oxidative stress, DNA damage, and inflammatory signaling pathways in the skin. By integrating clinical observation with experimental data, she aims to bridge the gap between bench and bedside. Her research is also aligned with translational goals, with implications for developing new topical agents or systemic therapies. Overall, Dr. Xu’s work demonstrates a commitment to unveiling the complex pathophysiology of dermatological conditions using advanced molecular tools and immunological analysis, with a focus on improving clinical outcomes and enhancing precision in dermatological treatment.

Research Skills

Dr. Xinya Xu possesses a diverse and advanced skill set that makes her an effective and innovative biomedical researcher. Her methodological strengths include cellular and molecular biology techniques, such as Western blotting, qPCR, immunofluorescence, and ELISA, which she applies to study skin cell behavior and immune responses in dermatological conditions. She is also proficient in cell culture and co-culture models to simulate in vitro skin environments. Dr. Xu has significant experience with flow cytometry and confocal microscopy, tools that are essential for her investigations into pyroptosis and immune cell activation in disorders like vitiligo. Her expertise in clinical data collection and statistical analysis ensures that her research is grounded in robust, reproducible evidence. Furthermore, she has demonstrated a high level of competence in manuscript preparation and grant writing, with successful funding from two major Guangdong provincial foundations. Her research process is marked by critical thinking, scientific rigor, and collaborative engagement, often involving multidisciplinary teams in dermatology, immunology, and pathology. In addition, Dr. Xu’s ability to manage both clinical and experimental research projects highlights her versatility and organizational skills. These capabilities allow her to contribute meaningful insights to dermatological science and maintain a trajectory of scholarly productivity and innovation.

Awards and Honors

Dr. Xinya Xu has received several awards and honors that affirm her excellence in academic achievement, research, and professional service. During her doctoral studies at Fudan University, she was awarded the Excellent Academic Scholarship consecutively in 2018, 2019, and 2020, recognizing her outstanding performance and scholarly commitment. Prior to that, she received the Outstanding Graduate Student Scholarship at Sun Yat-Sen University in 2016, demonstrating consistent academic excellence throughout her postgraduate training. On the international stage, she was honored with a Travel Award to attend the International Pigment Cell Conference in 2020, a recognition of her promising research contributions in pigment cell biology. Dr. Xu is also an active member of the Asian Society for Pigment Cell Research, which connects her with a broader academic community and fosters international collaboration. These recognitions reflect both her early promise and continued commitment to advancing dermatological science. Her achievements highlight not only academic merit but also her engagement with global research forums. Collectively, these accolades underscore her position as a rising leader in dermatological research, combining clinical insight with scientific innovation. They also reinforce her suitability for prestigious honors such as the Best Researcher Award.

Conclusion

Dr. Xinya Xu exemplifies the qualities of a well-rounded and impactful medical researcher. Her academic trajectory through respected institutions and her hands-on clinical experience at premier hospitals have equipped her with a strong foundation for research excellence. Her scientific output is marked by relevance, innovation, and clinical applicability—attributes evident in her multiple first-author publications on vitiligo, photoaging, and immunological skin disorders. She brings to her work a combination of clinical insight, laboratory precision, and translational intent. Her active participation in funded research projects and scholarly societies illustrates her commitment to scientific advancement and community engagement. Although further international collaboration and expanded thematic scope could enhance her academic influence, her current contributions already reflect a high level of professionalism and scientific rigor. With a proven track record in research, grantsmanship, and publication, Dr. Xu stands out as a deserving candidate for the Best Researcher Award. Her evolving work continues to add significant value to dermatological science, and her trajectory suggests ongoing contributions to both national and international research communities. She represents a model of emerging scientific leadership in clinical dermatology and biomedical research.

Publications Top Notes

  1. Title: Elevated CD47 Expression Impairs Elimination of Photoaged Fibroblasts by Macrophages and Serves as a Potential Biomarker for Photoaging
    Authors: Xu X#, Lu X#, Chen X, Yao A, Lai W
    Year: 2025
    Journal: Journal of Cosmetic Dermatology

  2. Title: Cytosolic mtDNA-cGAS-STING Axis Mediates Melanocytes Pyroptosis to Promote CD8⁺ T-Cell Activation in Vitiligo
    Authors: Xu X#, Lu X#, Zheng Y, Xie Y, Lai W
    Year: 2025
    Journal: Journal of Dermatological Science

  3. Title: New Insights into Segmental Vitiligo: A Clinical and Immunological Comparison with Nonsegmental Vitiligo
    Authors: Xu X, Jiang M, Zhang C, Qiao Z, Liu W, Le Y, Wu J, Ma W, Xiang LF
    Year: 2022
    Journal: Pigment Cell & Melanoma Research

  4. Title: Impact of Treatment Delays on Vitiligo During the COVID-19 Pandemic: A Retrospective Study
    Authors: Xu X#, Zhang C#, Jiang M, Xiang LF
    Year: 2021
    Journal: Dermatologic Therapy

  5. Title: Cathepsin D Contributes to the Accumulation of Advanced Glycation End Products During Photoaging
    Authors: Xu X#, Zheng Y#, Huang Y, Chen J, Gong Z, Li Y, Lu C, Lai W, Xu Q
    Year: 2018
    Journal: Journal of Dermatological Science

  1. Title: Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata
    Authors: Zhang L#, Xu X#, Chen S, Kang Y, Wang X, Zhang C, Xiang L
    Year: 2019
    Journal: Annals of Dermatology

  2. Title: Multiple Intracranial Hemorrhages in a Postmenopausal Female
    Authors: Lu X#, Xu X#, Zhang X
    Year: 2025
    Journal: Brain Pathology

 

David Botequim | Skin Diseases | Best Researcher Award

Dr. David Botequim | Skin Diseases | Best Researcher Award

Chief Medical Officer at Acie, Portugal

David José Roxo Botequim is an accomplished scientist and entrepreneur with a strong foundation in biotechnology, biosciences, and biomedical engineering. He has expertise in developing innovative solutions in medical diagnostics, biosensors, and clinical trials. Currently serving as Co-founder and Chief Medical Officer at Acie, he leads clinical trials and biosensor development. His research contributions span dermatological diseases, nanotechnology, and advanced biomaterials. David’s career reflects a balance between academia and industry, marked by innovative research, patents, and leadership roles. His interdisciplinary expertise positions him as a leader in advancing healthcare technologies and translational research.

Professional Profile

Education

David holds a Ph.D. in Biotechnology and Biosciences from Instituto Superior Técnico (IST), Universidade de Lisboa, where his thesis focused on fluorescently-labeled DNA probes for enhanced nucleic acid detection. He earned an Advanced Studies Diploma in Bioengineering from the MIT Portugal Program and an Integrated Master’s in Biomedical Engineering from NOVA School of Science and Technology. His educational journey also includes international exposure as a visiting Ph.D. student at Eindhoven University of Technology and specialized training in clinical trials and nanobiotechnology, underscoring his commitment to innovation and applied research.

Professional Experience

David’s career includes roles as a Co-founder and Chief Medical Officer at Acie, where he focuses on biosensor development and clinical trials. As a Post-Doctoral Researcher at Instituto de Medicina Molecular João Lobo Antunes, he investigated neutrophils in psoriasis, managing laboratory operations and mentoring students. His prior roles include Assistant Researcher at Matera, where he developed antimicrobial nanomaterials, and Research Fellow at CQE, contributing to disease diagnostics through nanotechnology. David has excelled in both academic and corporate environments, showcasing his ability to lead multidisciplinary projects, secure funding, and translate research into practical applications.

Research Interests

David’s research interests lie at the intersection of biotechnology, nanotechnology, and biomedical engineering. He focuses on developing advanced biosensors, fluorescent nanomaterials, and diagnostic tools for applications in dermatological diseases, infectious diseases, and cancer. His work also explores antimicrobial coatings, clinical trials, and the functional characterization of immune cells. David’s interdisciplinary approach integrates molecular biology, surface engineering, and fluorescence technologies to address critical challenges in medical diagnostics and healthcare innovation.

Research Skills

David is proficient in molecular biosensing, fluorescence microscopy, and advanced nanomaterial functionalization. He has expertise in techniques such as flow cytometry, spectrophotometry, and atomic force microscopy. David has extensive experience in designing and conducting clinical trials, managing laboratory operations, and mentoring students. His skills also include grant writing, project management, and collaboration with interdisciplinary teams, enabling him to drive innovation in both academic and industrial settings.

Awards and Honors

David’s achievements include being an inventor of a patented antimicrobial complex and securing grants from organizations like Fundação para a Ciência e a Tecnologia (FCT). He has delivered presentations at national and international conferences, earning recognition for his contributions to biosensor development and dermatological research. His distinction as a Ph.D. graduate with honors highlights his academic excellence and commitment to advancing scientific knowledge.

Conclusion

David Botequim’s blend of academic excellence, entrepreneurial leadership, and interdisciplinary research makes him a strong candidate for the Best Researcher Award. His contributions to biosensor technology, clinical trials, and nanotechnology demonstrate significant innovation and impact. While his strengths are evident in translational research and collaboration, he could further expand his international outreach and secure additional large-scale research funding. Overall, David’s work embodies the spirit of scientific innovation and societal advancement, making him a deserving candidate for this recognition.

Publication Top Notes

  1. Photosensitization of human skin fibroblasts by vemurafenib promotes pleiotropic effects on membrane-enclosed organelles and apoptosis
    Authors: Alpalhão, M., Botequim, D., Ferreira, J., Santus, R., Filipe, P.
    Year: 2023
    Citations: 1
  2. Merging Porphyrins with Gold Nanorods: Self Assembly Construct to High Fluorescent Polyelectrolyte Microcapsules
    Authors: Serra, V.V., Serra, S.G., Vallejo, M.C.S., Neves, M.G.P.M.S., Costa, S.M.B.
    Year: 2022
    Citations: 4
  3. Fluorescence spectroscopy of porphyrins and phthalocyanines: Some insights into supramolecular self-assembly, microencapsulation, and imaging microscopy
    Authors: Teixeira, R., Serra, V.V., Botequim, D., Andrade, S.M., Costa, S.M.B.
    Year: 2021
    Citations: 18
  4. Monitoring Proteolytic Activity in Real Time: A New World of Opportunities for Biosensors
    Authors: Oliveira-Silva, R., Sousa-Jerónimo, M., Botequim, D., Paulo, P.M.R., Prazeres, D.M.F.
    Year: 2020
    Citations: 15
  5. Fluorescent dye nano-assemblies by thiol attachment directed to the tips of gold nanorods for effective emission enhancement
    Authors: Botequim, D., Silva, I.I.R., Serra, S.G., Costa, S.M.B., Paulo, P.M.R.
    Year: 2020
    Citations: 17
  6. Density gradient selection of colloidal silver nanotriangles for assembling dye-particle plasmophores
    Authors: Oliveira-Silva, R., Sousa-Jerónimo, M., Botequim, D., Prazeres, D.M.F., Paulo, P.M.R.
    Year: 2019
    Citations: 5
  7. Extreme Enhancement of Single-Molecule Fluorescence from Porphyrins Induced by Gold Nanodimer Antennas
    Authors: Francisco, A.P., Botequim, D., Prazeres, D.M.F., Laia, C.A.T., Paulo, P.M.R.
    Year: 2019
    Citations: 23
  8. Enhanced Fluorescence of a Dye on DNA-Assembled Gold Nanodimers Discriminated by Lifetime Correlation Spectroscopy
    Authors: Paulo, P.M.R., Botequim, D., Jóskowiak, A., Zijlstra, P., Costa, S.M.B.
    Year: 2018
    Citations: 16
  9. A systematic study of solution and processing parameters on nanofiber morphology using a new electrospinning apparatus
    Authors: Henriques, C., Vidinha, R., Botequim, D., Borges, J.P., Silva, J.A.M.C.
    Year: 2009
    Citations: 61
  10. Production and characterization of chitosan based nanofibers
    Authors: Borges, J.P., Botequim, D., Vidinha, R., Henriques, C., Silva, J.C.
    Year: 2008